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Abstract
Progress in personalized medicine is now being
translated to personalized nutrition. A recent proof-
of-concept study shows that the increase in blood
glucose levels after a meal is highly variable between
individuals, but can be predicted by using a
computational model that combines information from
gut microbiome profiles and dietary questionnaires.
This study raises questions about the usefulness of
universal diet recommendations, and suggests we
might need to move on to personalized diets.
Metabolic syndrome and nutrition
More than a third of adults in the Western world who
are over 20 years old have the metabolic syndrome [1].
The clinical definition of the metabolic syndrome varies
but it typically includes at least three of the following
symptoms: obesity, raised blood glucose levels, increased
blood cholesterol levels and increased blood pressure,
which together increase the risk of developing type 2
diabetes and cardiovascular disease. The common de-
nominator behind the metabolic syndrome is insulin
resistance, that is, a lack of sensitivity of peripheral
organs to insulin, which has emerged as the root mech-
anism explaining the occurrence of these disorders.
After eating a meal, blood sugar levels increase in re-
sponse to the absorption of digested nutrients. This
postprandial glycemic increase (that is, the postprandial
glycemic response (PPGR)) triggers secretion of insulin
by pancreatic β cells. Increased levels of circulating insu-
lin result in glucose uptake by peripheral organs, such as
the liver, muscles and adipose tissue, and a return of
blood glucose levels towards their normal physiological
concentrations. Insulin resistance reduces the ability of
the body to regulate blood glucose levels, which results
in an increased PPGR despite increased insulin
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secretion. Insulin resistance and an increased PPGR are
major risk factors for developing type 2 diabetes. In a
recent study published in Cell, the teams of Eran Elinav
and Eran Segal developed a personalized nutrition
approach to predict PPGRs [2].
The metabolic syndrome has devastating conse-
quences in economic and public health and in the qual-
ity of life of patients. Pharmacological approaches and
surgical interventions such as bariatric surgery are
effective in improving glycemic control and reducing
weight. In particular, bariatric surgery remains the only
effective way to cure type 2 diabetes. Despite the efficacy
of these strategies, stomach stapling surgery has associ-
ated risks, just as taking pills for weight loss.
Dietary interventions are the easiest changes to imple-
ment in patients with the metabolic syndrome and offer
a key lifestyle alternative to medication and surgery that
has minimal adverse effects. These diets tend to follow
universal guidelines, which recommend limiting the
number of ingested calories while reducing fat and
carbohydrate intake. These diets typically result in
weight loss and improvement of glycemic control
(reduction of PPGRs), but predicting which patients will
respond to a particular diet is hard. Prediction of meta-
bolic health in general, and PPGRs in particular, has
remained empirical; genetics only explains a small
amount of the variation in these factors and there is
currently no effective way of predicting how each indi-
vidual patient will respond to a particular diet.
The emerging role of the microbiome
Our gut bacteria, collectively known as our gut micro-
biome, have a massive role in influencing the develop-
ment of diabetes and obesity. The gut microbiome is
now recognized as a key driver of inter-individual
variation in the likelihood of developing obesity and
diabetes. Individual microbiomes tend to cluster into
enterotypes, which are communities within a statistical
continuum that tend to be dominated by one phylum.
Enterotypes are independent of age, sex and geograph-
ical location. Long-term dietary habits tend to influence
these enterotypes. High intake of animal protein and fat,
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Dumas Genome Medicine  (2016) 8:7 Page 2 of 3in particular, favors the growth of Bacteroides, whereas
carbohydrate intake promotes growth of Prevotella
species [3]. Several studies have demonstrated that high
ecological diversity of gut microbes is associated with
good health, which is presumably due to an increase in
the diversity of bacterial functions. Owing to progress in
sequencing technologies, it is now possible to measure
almost every microbial gene in the microbiome and even
a simple measure such as counting the total number of
genes (microbial gene richness) shows an intriguing rela-
tionship of this number with metabolic health. Patients
with a low microbial gene count tend to have more se-
vere obesity, have more inflammation and gain more
weight than patients with a high microbial gene count
[4]. Patients with a low microbial gene count also re-
spond better to dietary intervention than patients with a
high microbial gene count [5]. Hence, the microbiome is
now emerging as both a biomarker and an actionable
target responding to dietary intervention in personalized
medicine.
From personalized medicine to personalized
nutrition
A recent article by Zeevi et al. combines longitudinal
monitoring of PPGRs by wearable continuous glucose
monitors, microbiome profile data and clinical informa-
tion in a large cohort. The findings show that although
individual PPGRs are hypervariable, they are predictable
by “big data” strategies, and suggest that personalized
diets might be more successful than universal diets in
controlling PPGRs. The researchers integrated various
data types, including information on dietary intakes,
anthropometric measurements, physical activity, sleep–
wake cycles, high-resolution long-term blood glucose
monitoring and fecal metagenomics in a cohort of
healthy and pre-diabetic volunteers [2]. The 800 volun-
teers self-reported nearly 10 million calories consumed
over nearly 47 thousand meals and automatically cap-
tured 1.5 million glucose measurements using ergo-
nomic and minimally invasive continuous glucose
monitors. In the first part of the study, Zeevi et al. estab-
lished that PPGRs are highly variable, which suggests
that universal dietary recommendations might have lim-
ited utility.
Having demonstrated the hypervariable nature of
PPGRs, Zeevi and colleagues then analyzed individual
anthropometric measurements, activity parameters and
microbiome profiles to predict these responses. The re-
searchers devised a machine-learning algorithm that is
based on a gradient-boosting regression methodology, in
which thousands of decision trees were derived to
optimize the predictive value of the overall model. Care-
ful calibration, with participants eating standardized
meals, enabled the machine-learning algorithm to makeprecise predictions for real-life meals by bringing extra
noise and coarse-grained resolution to the predictions,
which are critical factors for modeling the human elem-
ent in clinical studies. The investigators trained their
model in the cohort of 800 individuals by using leave-
one-out cross-validation and validated the model against
an independent cohort of 100 volunteers.
Finally, Zeevi and colleagues used their gradient-
boosting regression approach to design personally tai-
lored dietary interventions, aiming at improving PPGRs
in a two-arm blinded randomized controlled trial. Fol-
lowing the acquisition of baseline data, use of the
machine-learning algorithm improved PPGRs as well as
expert-based diet selection approaches.
Key findings and significance of the study
The novel approach introduced by Zeevi et al. makes it
possible to tailor diets to each individual. Although there
was a high level of interpersonal variation among
PPGRs, these were reproducible per person and per
standardized meal and were associated with known risk
factors. PPGR variability was also associated with clinical
markers of diabetes (glycated hemoglobin levels), obesity
(body mass index), liver function (alanine aminotransfer-
ase levels), inflammation (C-reactive protein levels), and,
most importantly, with microbiome profiles. The bacter-
ial taxa and microbial functions underlying these predic-
tions were highly consistent with previous reports in the
field, which further supports the robustness of the
approach.
This work is an important proof-of-concept study that
incorporates the contribution of the microbiome in the
prediction of dietary responses. The approach is part of
a new translational aspect of microbiome research.
Other studies have pioneered the use of genome-scale
modeling of microbiome responses to dietary interven-
tion, which predicted short-chain fatty acid and amino
acid variation in blood [6]. The combination of large-
scale volunteer recruitment with longitudinal phenotyp-
ing depth enabled the machine-learning algorithm to
outperform current models and expert-based predic-
tions, making this study a cornerstone in the field of per-
sonalized nutrition. This study further supports the role
of the microbiome as a prodromal marker—i.e., an early
predictive marker—in pathophysiology. From a compu-
tational medicine angle, the study highlights the power
of harnessing deep, longitudinal phenotyping by ‘big
data’ strategies, which is critical to crack the code of
complex individual response patterns and achieve indi-
vidual predictions.
Remaining challenges and future directions
This visionary study will undoubtedly influence the
setup of nutritional interventions for the metabolic
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personalized diets based on big data predictions out-
weigh surgical and pharmacological interventions? Can
metagenomic profiles and big data be used to gain a dee-
per understanding of the roles played by the microbiome
in metabolic diseases? By adding more constraints to the
machine-learning algorithm, is it possible to improve
PPGRs whilst reducing aortic plaque formation or sys-
temic inflammation?
This work clearly opens up new perspectives in the
improvement of tailored dieting strategies, but a
remaining challenge is increasing the availability of the
enabling technology and the assessment of this
machine-learning strategy in multicentric studies in vari-
ous populations. Nonetheless, deploying these deep phe-
notyping and metagenomic strategies would certainly
help patients with impaired glucose tolerance and
obesity to have truly personalized diets. The ability to
generate a personal baseline database including anthropo-
metric measurements, blood test data, microbiome pro-
files and dietary reports obtained with smartphone-based
apps is a powerful tool in terms of public health, patient
engagement and patient outreach.
This work illustrates the global push for long-term
phenotyping [7], metabolomics-assisted decision-making
in surgical environments [8] and predicting the out-
comes of toxicological interventions [9]. We are witnes-
sing the marriage of deep metagenomics with wearable
technology in personalized nutrition. This methodology
is likely to affect patient handling in nutritional interven-
tions, with diet recommendations probably shifting from
universal guidelines, often criticized, to personalized
diets. For optimal diets, bring on the personalized data
deluge!
Abbreviation
PPGR: postprandial glycemic response.
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